Outlook on the 3D Bioprinting Global Market to 2027 – Surging Focus on Regenerative Medicine is Driving Growth – QNT Press Release

DUBLIN, Nov. 24, 2022 /PRNewswire/ — The “3D Bioprinting Market – Global Outlook and Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering.

The global 3D Bioprinting market is expected to grow at a CAGR of 18.45% during 2022-2027.

The 3D Bioprinting is a technique that allows the production of biocompatible materials and complex 3D functional living tissues. It has enabled numerous researchers and manufacturers to mimic the natural tissue microenvironment into an in-house printed 3D tissue inmmense model. It has an act i field of medicine and healthcare.

The 3D bioprinting market focuses on developing application-specific bio-inks and new biomaterials, which are crucial in advancing Bio-printing tissues and organs for clinical use. Bioprinters and bio-printed tissues have gained significant interest in medicine and pharmaceuticals. Besides, bioprinting technology has a broad utility in various application areas such as tissue engineering and regenerative medicine (RM), transplantation, cancer research and drug screening, and high-throughput assays.

Bioprinting technology has the most recognized application in tissue engineering. Bioprinters are used to manufacture scaffolds and fabricate anatomically correct patient-specific constructs. , and engraftment with the host. Bioprinting’s future application is expected to be mostly in organ transplantation and drug & toxicity screening.

4D bioprinting can overcome many limitations of 3D printing; hence, it has become a new field in RM and tissue engineering markets. When compared to 3D printing, 4D printing offers various advantages such as fast growth of smart and multi-materials, more flexible and deformable structures, and can add more potential applications to both 4D and 3D printing. The emergence of 4D bio-printing is gaining momentum in disease management and healthcare innovation.

Limitations and Future Challenges

  • Bio-inks with lower biocompatibility and mechanical strength
  • Lower resolution and speed of bioprinter
  • Vasculature of tissue structures/constructs is an important challenge in Bio-printing as the tissues need continuous nutrients and oxygen.
  • Ethical and legal issues with 3D Bioprinting
  • The high cost of the method makes it unaffordable to developing countries.
  • Because Bio-printing is a new and novel technology, it should be studied appropriately to ensure it will be safe for humans.
  • Numerous Bioprinting companies have emerged in the market. Bioprinting can become a new gold standard for the bio-fabrication of tissues in the field of regenerative medicine.
  • About 80% of the market comprises established companies, while 20% are start-ups with strong economic growth. Among all types of bioprinters, extrusion-based bioprinters are used most widely because of their lower cost and ease to use. In comparison, the The second most common Bio-printing technology is Inkjet-based. Currently, inkjet technology is included in most extrusion-based bioprinters, commercially available as an additional printing head.
  • Stereolithography-based bioprinters are a new addition to the bio-printing industry. Laser-assisted bioprinters are one of the most expensive bioprinters. Laser-assisted bioprinters can reach the highest resolutions on the market. The global bioprinting market is growing at a faster rate Not only in terms of quantity but also in terms of diversification of the technologies developed and offered. The bioprinting companies are relatively dispersed across all continents. Globally, the US remains the most significant player, exceeding all the other countries. Several companies Bio-printing across the globe currently manufacture commercially available 3D bioprinters, which indicates that the field of Bio-printing is growing rapidly, and many start-ups are entering the market. The technological innovations associated with bioprinters and bio-inks are also increasing rapidly.

Technological Advancements

  • One of the biggest trends in technological innovations is the development of magnetic bioprinters, Organ. But, a magnetic bioprinter was developed by a Russian company, 3D Bioprinting Solutions. Furthermore, the Japanese company …

Full story available on Benzinga.com

Source link

Recommended For You

About the Author: News Center